Skip to main content
iwCLL 2023 Main banner
Final Program


iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Dimitar G. Efremov, MD

Head, Molecular Hematology Unit
International Centre for Genetic Engineering and Biotechnology
Trieste, Friuli-Venezia Giulia, Italy

Dimitar Efremov, MD, PhD, is Head of the Molecular Hematology Group of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste, Italy, and Visiting Professor of Internal Medicine at the Faculty of Medicine and Full Member of the Macedonian Academy of Sciences and Arts in Skopje, North Macedonia.
Dr. Efremov obtained his MD degree at the Faculty of Medicine in Skopje, where he also completed his specialization in internal medicine and training in hematology. He obtained his PhD degree from the Faculty of Medicine, Maastricht University, Maastricht, the Netherlands, and received postdoctoral training at the Medical College of Georgia, Augusta, GA, USA. He worked as an Associate Professor of Internal Medicine/Hematology at the Faculty of Medicine in Skopje until 2003, when he moved to Italy and established the Molecular Hematology Group of ICGEB.
Dr. Efremov’s primary research interest is chronic lymphocytic leukemia, particularly the molecular mechanisms governing the development and progression of the disease and identification of novel targeted therapies. Among his most notable achievements are the first preclinical studies demonstrating activity of B cell receptor inhibitors in chronic lymphocytic leukemia and studies identifying the mechanisms through which the B cell receptor contributes to the growth and survival of CLL cells. He has received numerous awards for his research, including prestigious grants from the Leukemia & Lymphoma Society, the Italian Association for Cancer Research, and the European Union.

Presentation(s):

Email Dimitar G.